A detailed history of Susquehanna Fundamental Investments, LLC transactions in Pulmonx Corp stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 61,405 shares of LUNG stock, worth $478,344. This represents 0.01% of its overall portfolio holdings.

Number of Shares
61,405
Previous 75,260 18.41%
Holding current value
$478,344
Previous $477 Million 99.91%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$5.93 - $7.71 $82,160 - $106,822
-13,855 Reduced 18.41%
61,405 $416,000
Q2 2024

Aug 15, 2024

BUY
$5.77 - $9.82 $434,250 - $739,053
75,260 New
75,260 $477 Million

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $290M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.